#South Korea #Seoul #Sky Labs #CART BP #OMRON Ventures

Investment Boost for Sky Labs

Sky Labs has made significant strides in its pursuit of expanding into the global healthcare market by securing strategic investments from OMRON Ventures, the corporate venture capital arm of the OMRON Group. Announced on November 4, 2025, this partnership is part of a broader initiative to escalate their business endeavors beyond mere financial attractions. This collaboration signals a belief in Sky Labs' innovative technology, particularly its groundbreaking product, the CART BP, designed for continuous blood pressure monitoring.

A Partnership for Progress

In addition to the investment from OMRON Ventures, Sky Labs has entered into a Memorandum of Understanding (MoU) with OMRON Healthcare, a global leader in blood pressure monitoring. The relationship between these two corporations dates back to a previous MoU signed in 2024, which focused on the global distribution and business development for the CART BP product line. This fostered a strong foundation for their current partnership and positions both companies leverage their strengths to fight against chronic health conditions.

The Innovation of CART BP

The CART BP device, a cuffless ring-type blood pressure monitor, is paving the way for new possibilities in hypertension management. It allows for seamless monitoring of blood pressure throughout daily activities, including sleep, which aids in early detection and prevention of hypertension-related complications. Its significant advantage is its ability to provide data trends over time, helping users to visualize fluctuations in their health metrics without the constraints of traditional monitoring methods.

Sky Labs' CEO, Jack Byunghwan Lee, expressed pride in the recognition of their technology. He stated that this partnership is a testament to the clinical effectiveness and the practical application of their innovations on a global scale. The CART BP's capabilities to monitor blood pressure continuously and provide comprehensive data set Sky Labs apart in the crowded landscape of healthcare technology.

OMRON’s Leadership in the Market

OMRON Healthcare has established itself as a powerhouse in the industry, renowned for its medical devices and cardiovascular management solutions, which have been made available in over 130 countries. To date, OMRON has sold over 400 million blood pressure monitoring units globally, continuously pushing the envelope by innovating products and solutions to enhance accuracy in home healthcare settings. Their commitment to expanding access to reliable health monitoring aligns perfectly with Sky Labs’ mission and product offerings.

Future Endeavors

The partnership aims not just at immediate benefits but at paving the way for future innovations in healthcare monitoring technology. Both firms are poised to make notable advancements in chronic disease management and to raise awareness of preventive healthcare measures around the globe. As they integrate their expertise and resources, they aim to elevate patient care and the quality of life for those managing chronic conditions.

Sky Labs, founded in 2015, originally made waves with its CART (Cardio Tracker) technology designed to capture heart signals through optical sensors. Its continual evolution led to the creation of the CART BP, which represents a significant leap forward in empowering patients with real-time health data. Their collaboration with Daewoong Pharmaceutical for domestic distribution within South Korea is a next step in promoting sales to a wider audience, encompassing hospitals, clinics, and general consumers.

The positive reception and rapid development of CART BP situate Sky Labs favorably in the burgeoning healthcare tech industry, and with the backing of OMRON, the future seems remarkably bright for this innovative startup.